Studying microbes in prostate cancer tumors
Part of Cancer, Kidney & urinary clinical trials.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 18 or older.
- You are being checked for prostate cancer or have been diagnosed with it and are having more tests or joining another trial.
- Your doctor says it is safe for you to have a fresh biopsy or surgery to get tumor tissue.
- You are willing to provide a fresh tumor sample and follow the study's sample collection rules.
- You have a record of your PSA test from the last 3 months.
- You do not have a bleeding disorder or other condition that would make a biopsy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial enrolls adults who are being evaluated or treated for possible or confirmed prostate cancer and allows researchers to collect prostate tissue. It may help improve understanding of prostate cancer over the course of diagnosis and standard care.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study looks at patients who have had a prostate biopsy or surgery to remove the prostate (radical prostatectomy). It aims to learn more about these procedures and how patients are doing.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.